C12N 2830/60
From viruses
Official title: from viruses
C12N2830/60 (From viruses) appears on 384 US grants and 426 published applications in this corpus.
Search patents in C12N- Granted patents
- 384
- Published applications
- 426
- Assignees
- 300
- Inventors
- 927
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 4 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 9 | 0 |
| 1997 | 10 | 0 |
| 1998 | 28 | 0 |
| 1999 | 15 | 0 |
| 2000 | 22 | 0 |
| 2001 | 24 | 3 |
| 2002 | 18 | 19 |
| 2003 | 13 | 41 |
| 2004 | 4 | 23 |
| 2005 | 13 | 32 |
| 2006 | 16 | 27 |
| 2007 | 22 | 15 |
| 2008 | 9 | 15 |
| 2009 | 6 | 15 |
| 2010 | 10 | 17 |
| 2011 | 11 | 15 |
| 2012 | 6 | 14 |
| 2013 | 13 | 8 |
| 2014 | 12 | 9 |
| 2015 | 8 | 30 |
| 2016 | 10 | 12 |
| 2017 | 18 | 22 |
| 2018 | 13 | 16 |
| 2019 | 13 | 19 |
| 2020 | 7 | 18 |
| 2021 | 9 | 7 |
| 2022 | 4 | 7 |
| 2023 | 9 | 4 |
| 2024 | 9 | 8 |
| 2025 | 6 | 19 |
| 2026 | 1 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and production of nicked closed-ended DNA vectors8 Sep 2026US 12,729,386 B2Generation Bio Co.
- Negative selection and stringency modulation in continuous evolution systems26 Aug 2025US 12,398,390 B2President and Fellows of Harvard College
- Genetically stable recombinant modified vaccinia Ankara (RMVA) vaccines and methods of preparation thereof24 Jun 2025US 12,337,032 B2City of Hope
- Genetic construct3 Jun 2025US 12,319,927 B2Healing Genes LLC
- Modified Marek's disease virus, and vaccines made therefrom22 Apr 2025US 12,280,106 B2Boehringer Ingelheim Animal Health USA Inc.
- Expression cassette coding for vascular endothelial growth factor8 Oct 2026US 2026/0308618 A1Cornell University
- Gene delivery vehicles comprising RNA and antibodies24 Sep 2026US 2026/0286387 A1uniQure biopharma B.V.
- Adeno-associated virus compositions for the treatment of facioscapulohumeral muscular dystrophy17 Sep 2026US 2026/0275379 A1Kate Therapeutics, Inc.
- Generation of adeno-associated virus capsid libraries for insect cells10 Sep 2026US 2026/0265729 A1uniQure biopharma B.V.
- Compositions and methods for the treatment of disorders related to frataxin deficiency10 Sep 2026US 2026/0265778 A1Voyager Therapeutics, Inc.
Most cited
By later US patents
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Genetic constructs for delaying or repressing the expression of a target gene369US 6,573,099 B2Benitec Australia Limited · 2003
- Packaging systems for human recombinant adenovirus to be used in gene therapy267US 5,994,128 AIntrogene B.V. · 1999
- Eukaryotic layered vector initiation systems204US 5,814,482 A1998
- Packaging systems for human recombinant adenovirus to be used in gene therapy178US 6,033,908 AIntrogene B.V. · 2000